Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Renger Tiessen"'
Autor:
Thijs van Iersel, Bernd Liedert, Steven Ramael, Ivo Sonderegger, Viktoria Moschetti, Benjamin Van Hoorick, Renger Tiessen, Sabrina Wiebe, Girish Jayadeva, Benjamin Lang
Publikováno v:
Rheumatology and Therapy. 5:403-421
BI 695501 has shown similar efficacy, safety, and immunogenicity to the adalimumab reference product, Humira®. We present two phase 1 studies comparing the pharmacokinetics, safety, and immunogenicity of BI 695501 delivered via autoinjector (AI) vs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8785abbbded17f06e957ac28a2cb6cfc
https://doi.org/10.1007/s40744-018-0119-1
https://doi.org/10.1007/s40744-018-0119-1
Autor:
Esther Peters, Jules A. A. C. Heuberger, Jacques Arend, Jasper Stevens, Renger Tiessen, Rosalinde Masereeuw, Peter Pickkers, Andrea van Elsas
Publikováno v:
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 55, 1227-37
Clinical Pharmacokinetics, 55, 10, pp. 1227-37
Clinical Pharmacokinetics, 55, 1227-37
Clinical Pharmacokinetics, 55, 10, pp. 1227-37
Background and Objective Previous clinical trials have suggested that bovine intestinal alkaline phosphatase has renal protective effects in patients with sepsis-associated acute kidney injury. We conducted a first-in-human study to investigate the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5859699ab8c41540aa1421ee261a0b2f
https://hdl.handle.net/2066/171174
https://hdl.handle.net/2066/171174
Autor:
Steven, Ramael, Benjamin, Van Hoorick, Renger, Tiessen, Thijs, van Iersel, Viktoria, Moschetti, Benjamin, Lang, Ivo, Sonderegger, Sabrina, Wiebe, Bernd, Liedert, Girish, Jayadeva
Publikováno v:
Rheumatology and Therapy
Introduction BI 695501 has shown similar efficacy, safety, and immunogenicity to the adalimumab reference product, Humira®. We present two phase 1 studies comparing the pharmacokinetics, safety, and immunogenicity of BI 695501 delivered via autoinje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7592e489a89bd9d22ef4e952d2009d3c
https://pubmed.ncbi.nlm.nih.gov/29959660
https://pubmed.ncbi.nlm.nih.gov/29959660
Autor:
Renger Tiessen, Jan Hartstra, Hamza Kandoussi, Heather Sevinsky, Berend Oosterhuis, Richard Bertz, Marc Bifano, Dennis M. Grasela, Maria Velinova-Donga, Carey Hwang
Publikováno v:
Antiviral therapy. 18(7)
Background Approximately one-third of all HIV-infected individuals are coinfected with HCV, many of whom will receive concomitant treatment for both infections. With the advent of direct-acting antivirals (DAAs) for HCV, potential drug interactions b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::805794c94cf06aadd3d0dbd7dfd21a61
https://pubmed.ncbi.nlm.nih.gov/23963204
https://pubmed.ncbi.nlm.nih.gov/23963204